At these levels, tirzepatide still activates both GLP-1 and GIP receptors, but the activation is gentler, more gradual, and far less likely to trigger the gastrointestinal side effects that make the first few weeks of standard dosing so difficult for many people
The company replies to 98% of negative reviews, typically within a week
Its been an amazing experience
Its typical role is for people already taking it for diabetes who get some weight benefit as a bonus, rather than people seeking maximum weight reduction
In recent years, several forms of GLP-1 receptor agonist drugs exclusively approved to treat type 2 diabetes have been widely used for their off-label weight loss benefits, with some of the most popular forms of these drugs including Tirzepatide (Mounjaro) and Semaglutide (Ozempic, Wegovy and Rybelsus)